Evidence map›Paper›PMID 19095933›Full record

ArticleScience (New York, N.Y.)2008

Transcription. Gene expression--where to start?

Stephen Buratowski

Abstract readComment
In one paragraph

Article in Science (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The case for junk DNA.PLoS genetics · 2014
    Article
  8. How bidirectional becomes unidirectional.Nature structural & molecular biology · 2013
    Article
  9. Review
  10. Article
  11. Article
  12. Promoter-associated RNAs and promoter-targeted RNAs.Cellular and molecular life sciences : CMLS · 2012
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Transcription. Repressive transcription.Science (New York, N.Y.) · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Stephen BuratowskiDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA. steveb@hms.harvard.edu

Funding

The RNA Polymerase II Transcription CycleR01GM056663 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Stephen Buratowski · 1999 to 2026
$11.7M
The RNA polymerase II transcription complexR01GM046498 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BURATOWSKI, STEPHEN · 1996 to 2024
$9.4M
NIGMS NIH HHS R01 GM046498NIGMS NIH HHS R01 GM056663
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Promoter Regions, GeneticTranscription, GeneticTranscription Initiation SiteEnhancer Elements, GeneticGene Expression ProfilingNucleosomesProtein BiosynthesisRNARNA, AntisenseRNA, MessengerRNA Polymerase IINucleosomesRNARNA, AntisenseRNA, MessengerRNA Polymerase II

Identifiers

PMID19095933
PMCPMC3516868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.